Ryan Maynard

Ryan Maynard

Director of Finance/CFO at FOGHORN THERAPEUTICS INC.
56 year
Health Technology
Technology Services
Electronic Technology

Profile

Mr. Ryan D.
Maynard
, CPA, is a Chief Financial & Accounting Officer at Foghorn Therapeutics, Inc. and an Independent Director at Iovance Biotherapeutics, Inc. He is on the Board of Directors at Iovance Biotherapeutics, Inc. Mr. Maynard was previously employed as a Chief Financial Officer by CARA Therapeutics, Inc., a Chief Financial Officer by Privapath Diagnostics Ltd., a Chief Financial Officer by Blade Therapeutics, Inc., a CFO, Executive VP & Head-Investor Relations by Rigel Pharmaceuticals, Inc., a Controller, Director-Finance & Accounting by Personify, Inc. (California), a Controller by General Magic, Inc., a Senior Manager-Finance by Siliconix, Inc., and a Chief Financial Officer by Paulus (Holdings) Ltd. He received his undergraduate degree from Santa Clara University.

Ryan Maynard active positions

CompaniesPositionStart
IOVANCE BIOTHERAPEUTICS, INC. Director/Board Member 15/02/2015
FOGHORN THERAPEUTICS INC. Director of Finance/CFO 22/02/2026

Former positions of Ryan Maynard

CompaniesPositionEnd
CARA THERAPEUTICS, INC. Director of Finance/CFO 31/03/2025
Director of Finance/CFO 28/02/2022
Director of Finance/CFO 31/05/2019
RIGEL PHARMACEUTICALS, INC. Director of Finance/CFO 30/12/2017
Director of Finance/CFO 31/03/2001
See the detail of Ryan Maynard's experience

Training of Ryan Maynard

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Electronic Technology

Technology Services

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Services

Finance

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!